Ying-Chung Hong

Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B

Yi‐Hsiang Huang, Liang-Tsai Hsiao, Ying-Chung Hong et al. · Journal of Clinical Oncology · 2013 · 327 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system

Chun‐Yu Liu, Muh‐Hwa Yang, Shu-Chiung Chiang et al. · Thrombosis and Haemostasis · 2012 · 112 citations

Medicine, Oncology, Cancer Epidemiology +14

Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma

Yu-Chung Huang, Chia‐Jen Liu, Chun‐Yu Liu et al. · Annals of Hematology · 2011 · 42 citations

Medicine, Immunology, Internal Medicine +12

Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: A nationwide population-based study

Sheng‐Hsuan Chien, Chia‐Jen Liu, Yu‐Wen Hu et al. · International Journal of Cancer · 2015 · 41 citations · Full text

Medicine, Oncology, Radiology +17

Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation—association with chronic GVHD in late-onset adult patients

Yao-Chung Liu, Jyh-Pyng Gau, Ying-Chung Hong et al. · Annals of Hematology · 2012 · 29 citations

Medicine, Hematology, Internal Medicine +10